SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cardiome -- CRME
CRME 2.330-2.1%May 16 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (147)4/30/2007 3:06:57 PM
From: keokalani'nui  Read Replies (1) of 285
 
Last cc, crme said they were in late innings (final approval processes) of in-licensing a pharma cpd in P1 expecting to start P2 next year. crme is looking at it for CV indications and has earmarked C$25m to acquire and develop it this yr. I don't have much to say, other than I'd prefer it if they kept the C$25m in their pockets and sold the company in 2008.

Only reason why lly would let go a legitimate cpd is they don't think the ultimate market is very large.

(Sorry Tuck, I see most of that was in the PR.)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News